The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Efficacy of Estradiol for the Treatment of Depressive Disorders in Perimenopausal Women: A Double-blind, Randomized, Placebo-Controlled Trial
Open accessAbstract
BACKGROUND: Results of previous studies suggest that estrogen improves somatic and mild depressive symptoms experienced by perimenopausal women. This study investigated the efficacy of 17beta-estradiol for the treatment of clinically significant depressive disorders in endocrinologically confirmed perimenopausal women. METHODS: Perimenopausal women (aged 40-55 years, with irregular menstrual periods and serum concentrations of follicle-stimulating hormone >25 IU/L), meeting criteria for major depressive disorder, dysthymic disorder, or minor depressive disorder, according to DSM-IV, were randomized to receive transdermal patches of 17beta-estradiol (100 microgram) or placebo in a 12-week, double-blind, placebo-controlled study. A 4-week washout period followed the 12-week treatment phase. Outcome measures were the Montgomery-Asberg Depression Rating Scale and Blatt-Kupperman Menopausal Index scores. RESULTS: Fifty women were enrolled in the study; 26 met DSM-IV criteria for major depressive disorder, 11 for dysthymic disorder, and 13 for minor depressive disorder. Remission of depression was observed in 17 (68%) women treated with 17beta-estradiol compared with 5 (20%) in the placebo group (P =.001). Subjects responded similarly to estradiol treatment, regardless of DSM-IV diagnosis. Patients treated with estradiol sustained antidepressant benefit of treatment after the 4-week washout period, although somatic complaints increased in frequency and intensity. Treatment was well tolerated and adverse events were rare in both groups. CONCLUSION: Transdermal estradiol replacement is an effective treatment of depression for perimenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Effects of gonadal steroids in women with a history of postpartum depression
Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.924 · Cited by 950
Spitzer, R. L., Williams, J. B. W., Kroenke, K., Hornyak, R., & McMurray, J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106580 · Cited by 847 · cited 1×
“The recruitment of subjects with depression who primarily sought treatment for physical symptoms in a gynecological outpatient clinic appears to be appropriate and consistent with previous reports showing that depressive disorders are frequently encountered in medical care settings.(40,41) In addition, their first app…”
ResultEstrogen replacement in perimenopause-related depression: A preliminary report
Schmidt, P. J., Nieman, L., Danaceau, M. A., Tobin, M. B., Roca, C. A., Murphy, J. H., & Rubinow, D. R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106004 · Cited by 578
Transdermal oestrogen for treatment of severe postnatal depression
Gregoire, A. J. P., Kumar, R., Everitt, B., & Studd, J. W. W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91414-2 · Cited by 562
Oestrogen Therapy and the Menopausal Syndrome
CAMPBELL, S., & WHITEHEAD, M. (1977) · Clinics in Obstetrics and Gynaecology · doi:10.1016/s0306-3356(21)00374-5 · Cited by 539
Avis, N. E., Brambilla, D., McKinlay, S. M., & Vass, K. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90099-x · Cited by 482
Ovarian steroids and the brain: Implications for cognition and aging
McEwen, B. S., Alves, S. E., Bulloch, K., & Weiland, N. G. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_7.8s · Cited by 482
The Manitoba Project: a re-examination of the link between menopause and depression
Kaufert, P. A., Gilbert, P., & Tate, R. (1992) · Maturitas · doi:10.1016/0378-5122(92)90006-p · Cited by 312
Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?
Joffe, H., & Cohen, L. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00169-3 · Cited by 283
Self-citationThe South-East England longitudinal study of the climacteric and postmenopause
Hunter, M. (1992) · Maturitas · doi:10.1016/0378-5122(92)90004-n · Cited by 257
EFFECT OF OESTROGEN AND TESTOSTERONE IMPLANTS ON PSYCHOLOGICAL DISORDERS IN THE CLIMACTERIC
Montgomery, J. C., Brincat, M., Tapp, A., Appleby, L., Versi, E., Fenwick, P. B. C., & Studd, J. W. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92026-5 · Cited by 255
Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting.
Coope, J., Thomson, J. M., & Poller, L. (1975) · BMJ · doi:10.1136/bmj.4.5989.139 · Cited by 239
Effect of oestrogen on the sleep, mood, and anxiety of menopausal women.
Thomson, J., & Oswald, I. (1977) · BMJ · doi:10.1136/bmj.2.6098.1317 · Cited by 222
Rates and risks of depressive symptoms in a United States urban community
Weissman, M. M., & Myers, J. K. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb06888.x · Cited by 197
Psychiatric morbidity and the menopause; screening of general population sample.
Ballinger, C. B. (1975) · BMJ · doi:10.1136/bmj.3.5979.344 · Cited by 187
Higgins, E. S. (1994) · Archives of Family Medicine · doi:10.1001/archfami.3.10.908 · Cited by 183
VITAMIN E AND CLIMACTERIC SYNDROME: Failure of Effective Control as Measured by Menopausal Index
BLATT, M. H. G. (1953) · A.M.A. Archives of Internal Medicine · doi:10.1001/archinte.1953.00240180101012 · Cited by 158
Affective Symptoms in Women Attending a Menopause Clinic
Hay, A. G., Bancroft, J., & Johnstone, E. C. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.513 · Cited by 148
Menopause-related affective disorders: a justification for further study
Schmidt, P. J., & Rubinow, D. R. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.7.844 · Cited by 131
KENDALL, D., Stancel, G. M., & Enna, S. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-03-00354.1982 · Cited by 115
Scott, R. T., Ross, B., Anderson, C., et al. (1991) · PubMed · Cited by 112
Smith, R. N. J., Studd, J. W. W., Zamblera, D., & Holland, E. F. N. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb11321.x · Cited by 90
Is oestrogen therapy effective in the treatment of menopausal depression?
Coope, J. (1981) · PubMed · Cited by 81
Delmas, P. D., Pornel, B., Felsenberg, D., Garnero, P., Hardy, P., Pilate, C., & Dain, M. (1999) · Bone · doi:10.1016/s8756-3282(99)00076-9 · Cited by 72
Transdermal delivery of drugs for the treatment of bone diseases
Ramachandran, C., & Fleisher, D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00062-4 · Cited by 68
The role of oestrogen replacement in the climacteric syndrome
Borth, R., Strickler, R. C., Cecutti, A., et al. (1977) · Psychological Medicine · doi:10.1017/s0033291700006280 · Cited by 62
A quality of life perspective on who benefits from estradiol replacement therapy
KARLBERG, J. P. E., Mattsson, L., & Wiklund, I. E. (1995) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349509024430 · Cited by 60
Scott, R. T., Ross, B., Anderson, C., et al. (1991) · Maturitas · doi:10.1016/0378-5122(91)90184-r · Cited by 53
Effect of oestradiol on postpartum depression
Ahokas, A., Kaukoranta, J., & Aito, M. (1999) · Psychopharmacology · doi:10.1007/s002130051095 · Cited by 47
Novaes, C. T. G., Almeida, O. P., & de Melo, N. R. (1998) · Climacteric · doi:10.3109/13697139809085553 · Cited by 45
Self-citationMontgomery-Åsberg severity gradations
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1320b · Cited by 39 · cited 1×
“Full remission was achieved if the end-of-treatment MADRS score was less than 10.(23) Decline of 50% or more on baseline BKMI scores was considered in-”
BackgroundDepression During the Perimenopause
Soares, C., & Almeida, O. P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.3.306 · Cited by 28
Self-citationDepression comes in many disguises to the providers of primary care: recognition and management.
Schuyler, D. (2000) · PubMed · Cited by 12
Cited by
Sex differences in anxiety and depression clinical perspectives
Altemus, M., Sarvaiya, N., & Neill Epperson, C. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.004 · Cited by 1,413
“In addition, two randomized clinical trials (Schmidt et al., 2000; Soares et al., 2001) indicate that typical hormone therapy doses of estradiol (50 or 100 lg/d) are significantly more effective than placebo in treating major depression with perimenopause onset, a finding that is lacking for major…”
BackgroundThe stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
Freeman, E. W., Sammel, M. D., Lin, H., & Nelson, D. B. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.375 · Cited by 893
Metadata
- Authors
- de Novaes Soares, C., Almeida, O. P., Joffe, H., & Cohen, L. S.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2001-06-01
- Volume
- 58
- Issue
- 6
- Pages
- 529
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2142604492
- Cited by
- 691
- References
- 36
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.